|The KIR2DL2 kir2dl2 (Catalog #MBS8252629) is a shRNA produced from E Coli and is intended for research purposes only. The product is available for immediate purchase. The KIR2DL2 shRNA Plasmid (Human) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s KIR2DL2 can be used in a range of immunoassay formats including, but not limited to, RNA interference (RNAi). Researchers should empirically determine the suitability of the KIR2DL2 kir2dl2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The KIR2DL2 kir2dl2 product has the following accession number(s) (GI #134304833) (NCBI Accession #NP_055034.2) (Uniprot Accession #P43627). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
shRNA Plasmid to inhibit KIR2DL2 expression by RNA interference.
Quality Control: The sequence of shRNA is guaranteed by sequencing. Directions for Use: Resuspend lyophilized shRNA plasmid DNA in 500 ul of the deionized water. Each vial contains 50 ug of lyophilized shRNA plasmid DNA. Suitable for up to 50 transfections.
Components: We offer 3 different plasmids which knock down human KIR2DL2 gene specifically. Each vial contains 50 ug of lyophilized shRNA. Blood tissues are correlated with this protein. Bronchial Neoplasms, Carcinoma, Hepatocellular, Cardiovascular Diseases, Chromosome Aberrations, Diabetes Mellitus, Inflammation, Lung Neoplasms, Necrosis, Neoplasms, Experimental, Skin Neoplasms are some of the diseases may be linked to KIR2DL2 shRNA Plasmid (Human). The following patways have been known to be associated with this gene.